AGAH RAMTIN (Chief Medical Officer) purchased 3.0% of their position (22K shares) of RENOVORX, INC. on the open market
Open‑market purchase worth $17.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/24/2025ACC: 0001493152-25-024875
DirectorOfficer10% Owner· Chief Medical Officer
Since Aug 2021
+22K
Net shares
Net buyer
$17.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
22K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$0.80
Trade value
$8K
% of position
1.4%
11/21/2025
734.46K→744.46K
Common Stock
Direct
Shares
+12K
Price / share
$0.80
Trade value
$9.60K
% of position
1.6%
11/24/2025
744.46K→756.46K
Total
Net shares
+22K
Net value
$17.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | P · Purchase | +10K | $0.80 | $8K | 1.4% | 734.46K | 744.46K |
| Common Stock Direct | 11/24/2025 | P · Purchase | +12K | $0.80 | $9.60K | 1.6% | 744.46K | 756.46K |
| Total | +22K | $17.60K | ||||||
Derivative Transactions0
No derivative transactions reported